ASX - By Stock
|
AVR |
Re:
Ann: AGM Chairman and CEO Presentation
|
|
daveg
|
42 |
12K |
1 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
42
|
12K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: DSMB Confirms Safety of First Patients Dosed
|
|
daveg
|
19 |
6.2K |
3 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
19
|
6.2K
|
3
|
|
ASX - By Stock
|
AGN |
Re:
Ann: DSMB Confirms Safety of First Patients Dosed
|
|
daveg
|
19 |
6.2K |
3 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
19
|
6.2K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity strengthens Cu-64 network with new supply agreement
|
|
daveg
|
50 |
13K |
6 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
50
|
13K
|
6
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Scoping Study Results Greater Duchess Project
|
|
daveg
|
97 |
34K |
6 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
97
|
34K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Ann: AGM Chairman and CEO Presentation
|
|
daveg
|
42 |
12K |
8 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
42
|
12K
|
8
|
|
ASX - By Stock
|
WA8 |
Re:
Ann: Melbourne Investor Seminar
|
|
daveg
|
80 |
13K |
0 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
80
|
13K
|
0
|
|
ASX - By Stock
|
WA8 |
Re:
Ann: Melbourne Investor Seminar
|
|
daveg
|
80 |
13K |
1 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
80
|
13K
|
1
|
|
ASX - By Stock
|
WA8 |
Re:
Ann: Melbourne Investor Seminar
|
|
daveg
|
80 |
13K |
1 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
80
|
13K
|
1
|
|
ASX - By Stock
|
WA8 |
Re:
Ann: Melbourne Investor Seminar
|
|
daveg
|
80 |
13K |
2 |
27/05/24 |
27/05/24 |
ASX - By Stock
|
80
|
13K
|
2
|
|
ASX - By Stock
|
TLM |
Re:
Ann: Latest Assays Further Expand Rip n Tear Prospect
|
|
daveg
|
12 |
5.0K |
3 |
25/05/24 |
25/05/24 |
ASX - By Stock
|
12
|
5.0K
|
3
|
|
ASX - By Stock
|
HIQ |
Re:
News: HIQ HitiQ Entered A$1.6 Million Convertible Note Facility With Harmil Angel Investments
|
|
daveg
|
5 |
1.4K |
2 |
24/05/24 |
24/05/24 |
ASX - By Stock
|
5
|
1.4K
|
2
|
|
ASX - By Stock
|
AGN |
Re:
Ann: DSMB Confirms Safety of First Patients Dosed
|
|
daveg
|
19 |
6.2K |
6 |
22/05/24 |
22/05/24 |
ASX - By Stock
|
19
|
6.2K
|
6
|
|
ASX - By Stock
|
HIQ |
Re:
News: HIQ HitiQ Entered A$1.6 Million Convertible Note Facility With Harmil Angel Investments
|
|
daveg
|
5 |
1.4K |
3 |
21/05/24 |
21/05/24 |
ASX - By Stock
|
5
|
1.4K
|
3
|
|
ASX - By Stock
|
CNB |
Re:
Ann: Application for quotation of securities - CNB
|
|
daveg
|
45 |
16K |
12 |
20/05/24 |
20/05/24 |
ASX - By Stock
|
45
|
16K
|
12
|
|
ASX - By Stock
|
CVB |
Re:
CVB Media Links
|
|
daveg
|
9 |
3.7K |
1 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
9
|
3.7K
|
1
|
|
ASX - By Stock
|
HIQ |
Re:
The AFL's 7 Point Plan
|
|
daveg
|
4 |
982 |
1 |
17/05/24 |
17/05/24 |
ASX - By Stock
|
4
|
982
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: ARG-007 Reduces Effects of TBI in Preclinical Study
|
|
daveg
|
16 |
5.7K |
9 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
16
|
5.7K
|
9
|
|
ASX - By Stock
|
HIQ |
Re:
Ann: Mar24 Quarterly Activities Statement and Appendix 4C
|
|
daveg
|
5 |
1.5K |
2 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
5
|
1.5K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
daveg
|
506 |
155K |
6 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
506
|
155K
|
6
|
|
ASX - By Stock
|
LLL |
Re:
Ann: MoU Signed with Mali Gov & Sale of Entire Project to Ganfeng
|
|
daveg
|
760 |
241K |
20 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
760
|
241K
|
20
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - Media and Industry News
|
|
daveg
|
180 |
68K |
4 |
08/05/24 |
08/05/24 |
ASX - By Stock
|
180
|
68K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
Research/Valuation
|
|
daveg
|
492 |
158K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
492
|
158K
|
1
|
|
ASX - By Stock
|
HIQ |
Re:
Ann: Mar24 Quarterly Activities Statement and Appendix 4C
|
|
daveg
|
5 |
1.5K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
5
|
1.5K
|
1
|
|
ASX - By Stock
|
DOC |
Re:
Ann: Annual General Meeting - Presentations and Addresses
|
|
daveg
|
4 |
1.2K |
2 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
4
|
1.2K
|
2
|
|
ASX - By Stock
|
CVB |
Re:
Ann: Investor Presentation - Quarterly Update - Q3 FY24
|
|
daveg
|
1 |
603 |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
1
|
603
|
1
|
|
ASX - By Stock
|
NWC |
Re:
Ann: Change in substantial holding
|
|
daveg
|
3 |
1.3K |
1 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
3
|
1.3K
|
1
|
|
ASX - By Stock
|
CUV |
Re:
Ann: SCENESSE European Orphan Drug Designation for XP
|
|
daveg
|
11 |
4.4K |
1 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
11
|
4.4K
|
1
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
daveg
|
506 |
155K |
15 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
506
|
155K
|
15
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
daveg
|
743 |
182K |
2 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
743
|
182K
|
2
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity launches $121 million equity raise
|
|
daveg
|
90 |
36K |
2 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
90
|
36K
|
2
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Application for quotation of securities - AGN
|
|
daveg
|
6 |
1.2K |
3 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
6
|
1.2K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Clarity launches $121 million equity raise
|
|
daveg
|
90 |
36K |
3 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
90
|
36K
|
3
|
|
ASX - By Stock
|
DOC |
Re:
$0.15 by end of July 23!
|
|
daveg
|
94 |
25K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
94
|
25K
|
0
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Argenica Successfully Completes $12.0m Placement
|
|
daveg
|
59 |
15K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
59
|
15K
|
3
|
|
ASX - By Stock
|
CU6 |
Re:
CU6 - ASX Charts
|
|
daveg
|
506 |
155K |
1 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
506
|
155K
|
1
|
|
ASX - By Stock
|
CEL |
Re:
Ann: Trading Halt
|
|
daveg
|
23 |
9.0K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
23
|
9.0K
|
0
|
|
ASX - By Stock
|
STK |
Re:
Ann: Acquisition of the 5.4Moz AuEq Rogozna Gold Project
|
|
daveg
|
77 |
31K |
1 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
77
|
31K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Argenica Successfully Completes $12.0m Placement
|
|
daveg
|
59 |
15K |
4 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
59
|
15K
|
4
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Argenica Successfully Completes $12.0m Placement
|
|
daveg
|
59 |
15K |
7 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
59
|
15K
|
7
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Argenica Successfully Completes $12.0m Placement
|
|
daveg
|
59 |
15K |
1 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
59
|
15K
|
1
|
|
ASX - By Stock
|
NWC |
Re:
Ann: Trading Halt
|
|
daveg
|
35 |
12K |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
35
|
12K
|
3
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Trading Halt
|
|
daveg
|
23 |
6.3K |
2 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
23
|
6.3K
|
2
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Trading Halt
|
|
daveg
|
23 |
6.3K |
6 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
23
|
6.3K
|
6
|
|
ASX - By Stock
|
AGN |
Re:
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007
|
|
daveg
|
49 |
15K |
1 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
49
|
15K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007
|
|
daveg
|
49 |
15K |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
49
|
15K
|
2
|
|
ASX - By Stock
|
AGN |
Re:
Ann: Trading Halt
|
|
daveg
|
23 |
6.3K |
4 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
23
|
6.3K
|
4
|
|
ASX - By Stock
|
AGN |
Re:
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007
|
|
daveg
|
49 |
15K |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
49
|
15K
|
2
|
|
ASX - By Stock
|
AGN |
Re:
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007
|
|
daveg
|
49 |
15K |
1 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
49
|
15K
|
1
|
|
ASX - By Stock
|
AGN |
Re:
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007
|
|
daveg
|
49 |
15K |
1 |
30/03/24 |
30/03/24 |
ASX - By Stock
|
49
|
15K
|
1
|
|